CALYXHA Overview

  • Founded
  • 2019
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Investors
  • 5

CALYXHA General Information


Developer of novel therapies based in Vienna, Austria. The company offers discovery related to tissue degeneration diseases, which is caused by a pathological process affecting the integrity and decreasing the functionality of tissues and organs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Karl-Farkas-Gasse 22
  • Vienna, 1030
  • Austria
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CALYXHA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 04-Mar-2020 Completed Generating Revenue
To view CALYXHA’s complete valuation and funding history, request access »

CALYXHA Executive Team (4)

Name Title Board Seat Contact Info
Robert Konrat Co-Founder & Chief Scientific Officer
Marco Sealey Co-Founder & Head of Discovery and Research
Tanja Gesell Co-Founder & Head of Research & Discovery Platform
Eszter Nagy Ph.D Co-Founder & Chief Executive Officer
To view CALYXHA’s complete executive team members history, request access »

CALYXHA Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARAX Capital Partners Venture Capital Minority 000 0000 000000 0
Kinled Holding Venture Capital Minority 000 0000 000000 0
Life Link Ventures Venture Capital Minority 000 0000 000000 0
Olipan Investments Venture Capital Minority 000 0000 000000 0
The Blom Family Office Family Office Minority 000 0000 000000 0
To view CALYXHA’s complete investors history, request access »